- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Mar 31, 2025 | 127.78M sh |
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $408.74M |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $422.03M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $13.39B |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $12.07B |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $5.61B |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $7.31B |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $15.52B |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $17.22B |
| Current Assets | Q3 2025 · Mar 31, 2025 | $6.78B |
| Current Assets | Q3 2025 · Jun 30, 2024 | $6.8B |
| Total Assets | Q3 2025 · Mar 31, 2025 | $28.92B |
| Total Assets | Q3 2025 · Jun 30, 2024 | $29.3B |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 130.59M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 130.17M sh |
| Stock Repurchased | Q3 2025 · Mar 31, 2024 | $240.89M |
| Dividends Paid | Q3 2025 · Mar 31, 2024 | $571.58M |
| Capex | Q3 2025 · Mar 31, 2024 | $283.33M |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | $2.15B |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $5.56 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | $15.82 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $5.65 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $16.03 |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $816.34M |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $2.5B |
| Operating Income | Q3 2025 · Mar 31, 2024 | $1.03B |
| Operating Income | Q3 2025 · Mar 31, 2024 | $2.98B |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $3.28B |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $9.48B |
| Revenue | Q3 2025 · Mar 31, 2024 | $5.07B |
| Revenue | Q3 2025 · Mar 31, 2024 | $14.74B |